1.7200
25-November-24 16:45:01
15 minutes delayed
Stocks
+0.0200
+1.18%
Today's range
1.6800 - 1.8100
ISIN
N/A
Source
NASDAQ
PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value
07 Oct 2022 09:00:00 By Nasdaq GlobeNewswire